CAMP
CAMP4 Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 3
Consensus Rating "Buy"
Bearish Engulfing
Ample Liquidity
High Gross Profit Margin
EPS Below Expectations
Consecutive Revenue Decline
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About CAMP
Camp4 Therapeutics Corporation
A biopharmaceutical company that uses RNA based regulatory therapy to treat various genetic diseases in clinical stages
One Kendall Square, Building 1400 West, 3rd Floor, Cambridge, Massachusetts 02139
--
CAMP4 Therapeutics Corporation was originally incorporated in Delaware in 2015 and began operations in 2016. They are a clinical-stage biopharmaceutical company that has pioneered the discovery and development of RNA-based regulatory therapies designed to up-regulate gene expression and restore healthy protein levels for the treatment of various genetic diseases. Regulatory RNAs, or regRNAs, play a central role in the regulation of each protein-coding gene by promoting gene activation and suppression. Their method aims to amplify the expression of messenger RNA or mRNA by harnessing the power of regRNAs, which form local complexes with transcription factors and regulate gene expression. Their proprietary RNA drive platform, or RAP platform, enables them to rapidly and systematically identify and characterize the active regulatory elements that control each expressed gene and the tens of thousands of druggable enhancers and promoter regRNA sequences that control protein-coding genes.
Company Financials
EPS
CAMP has released its 2025 Q3 earnings. EPS was reported at -0.55, versus the expected -0.48, missing expectations. The chart below visualizes how CAMP has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
CAMP has released its 2025 Q3 earnings report, with revenue of 795.00K, reflecting a YoY change of NaN%, and net profit of -15.10M, showing a YoY change of -11.98%. The Sankey diagram below clearly presents CAMP's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
